Yan Yuetian, Xing Tao, Wang Shunhai, Li Ning
Analytical Chemistry Group, Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707, United States.
J Am Soc Mass Spectrom. 2025 Jul 2;36(7):1518-1526. doi: 10.1021/jasms.5c00089. Epub 2025 Jun 11.
Integration of Asymmetrical Flow Field-Flow Fractionation (AF4) with online native mass spectrometry (MS) is an attractive concept that offers significant value for the analytical characterization of protein therapeutics. Its execution, however, is challenged by the incompatibility of mobile phase components and the difficulties of achieving sensitive MS detection without compromising the separation efficiency. Herein, we describe in detail the successful coupling of a commercial AF4 instrument with online native MS detection. By optimizing the operational conditions of AF4 using ammonium acetate-based mobile phases and fine-tuning the interface configurations, the established AF4-MS platform achieved uncompromised separation performance while enabling sensitive online native MS measurements. The feasibility of the method for studying protein analytes was first demonstrated by analyzing a protein mixture sample (17 kDa to 660 kDa), followed by size variant characterization of the NISTmAb. The AF4-MS method was subsequently compared with native SEC-MS using both protein mixture and mAb samples, highlighting their complementarity as size-based separation techniques and showcasing the quantitative advantages of AF4-MS. Applications of AF4-MS in supporting therapeutic mAb development were demonstrated using two case studies, including heterodimer quantitation in a coformulated mAb cocktail sample and antibody-antigen binding stoichiometry characterization. This developed AF4-MS method is easily implementable and could be a valuable addition to our analytical toolbox to support therapeutic mAb development.
将不对称流场-流分馏(AF4)与在线原生质谱(MS)联用是一个颇具吸引力的概念,可为蛋白质治疗药物的分析表征提供重要价值。然而,其实施面临流动相成分不相容以及在不影响分离效率的情况下实现灵敏质谱检测的困难等挑战。在此,我们详细描述了商用AF4仪器与在线原生质谱检测的成功联用。通过使用基于醋酸铵的流动相优化AF4的操作条件,并微调接口配置,所建立的AF4-MS平台在实现灵敏的在线原生质谱测量的同时,保持了分离性能不受影响。该方法用于研究蛋白质分析物的可行性首先通过分析蛋白质混合物样品(17 kDa至660 kDa)得到证明,随后对NISTmAb进行了大小变异体表征。随后使用蛋白质混合物和单克隆抗体样品将AF4-MS方法与原生尺寸排阻色谱-质谱(SEC-MS)进行了比较,突出了它们作为基于大小的分离技术的互补性,并展示了AF4-MS的定量优势。通过两个案例研究展示了AF4-MS在支持治疗性单克隆抗体开发中的应用,包括在共配制的单克隆抗体混合物样品中进行异二聚体定量以及抗体-抗原结合化学计量表征。这种开发的AF4-MS方法易于实施,可能是我们支持治疗性单克隆抗体开发的分析工具箱中的一项有价值的补充。